

- #Philippines corona tracker update
- #Philippines corona tracker trial
- #Philippines corona tracker plus
An interim distribution forecast, most recently published 3 February, can be found here. The most up-to-date forecast of COVAX's vaccine supply can be found here. CEPI’s candidates from companies Inovio, Moderna, CureVac, Institut Pasteur/Merck/Themis, AstraZeneca/University of Oxford, Novavax, University of Hong Kong, Clover Biopharmaceuticals, and University of Queensland/CSL are part of the COVAX initiative. The goal is to work with vaccine manufacturers to offer low-cost COVID-19 vaccines to countries.
#Philippines corona tracker trial
ACTIV aims to fast-track development of drug and vaccine candidates for COVID-19.ĬOVPN: The COVID-19 Prevention Trials Network (COVPN) combines clinical trial networks funded by the National Institute of Allergy and Infectious Diseases (NIAID): the HIV Vaccine Trials Network (HVTN), HIV Prevention Trials Network (HPTN), Infectious Diseases Clinical Research Consortium (IDCRC), and the AIDS Clinical Trials Group.ĬOVAX: The COVAX initiative, part of the World Health Organization’s (WHO) Access to COVID-19 Tools (ACT) Accelerator, is being spearheaded by the Coalition for Epidemic Preparedness Innovations (CEPI) Gavi, the Vaccine Alliance and WHO. OWS is “part of a broader strategy to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.”ĪCTIV: Within OWS, the US National Institutes of Health (NIH) has partnered with more than 18 biopharmaceutical companies in an initiative called ACTIV. OWS has funded JNJ-78436735 (Janssen), mRNA-1273 (Moderna), and NVX‑CoV2373 (Novavax), V590 (Merck/IAVI), V591 (Merck/Themis), AZD1222 (AstraZeneca/University of Oxford), and the candidate developed by Sanofi and GlaxoSmithKline.
#Philippines corona tracker update
If you wish to submit an update or notice an issue with this data, please email Focus at 10 June with new information on vaccines from Pfizer/BioNTech, Moderna, Novavax, and Baylor College of Medicine as well as the vaccine candidate from Walvax Biotechnology Co., Ltd.ĬOVID-19 vaccine initiatives OWS: Operation Warp Speed is a collaboration of several US government departments including Health and Human Services (HHS) and subagencies, Defense, Agriculture, Energy and Veterans Affairs and the private sector. Information about the unprecedented public/private partnerships spawned by the COVID-19 public health emergency now can be found below the charts.
#Philippines corona tracker plus
To reveal in-depth information about each candidate, select the “Details” button above the chart or click on the green plus button next to each entry. The first chart details vaccine candidates that are still in development to address the lack of vaccines and access in many countries around the world the second chart lists vaccines that are authorized or approved by one or more country. To clarify the landscape for our readers, our vaccine tracker has been split in two. Coronavirus vaccine roll out statistics by country Philippines, 150,995,394, 1,415.8 Iran, 149,957,751, 1,785.4 United Kingdom, 148,549,749, 2,234.2 Turkey. Dozens of vaccines now have been authorized or approved around the globe many more remain in development. The worldwide endeavor to create a safe and effective COVID-19 vaccine is bearing fruit.
